The trading price of Acurx Pharmaceuticals Inc (NASDAQ:ACXP) closed higher on Tuesday, June 17, and closing at $0.82, 167.24% higher than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $3.33 and a 52-week low of $0.30. Over the past month, the stock has gained 112.07% in value.
Acurx Pharmaceuticals Inc, whose market valuation is $19.27 million at the time of this writing, is expected to release its quarterly earnings report in July. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.1 per share this quarter, however they have predicted annual earnings per share of -0.45 for current year and -0.47 for next year.
On the technical side, indicators suggest ACXP has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently Hold.
A quick review shows that ACXP’s price is currently 111.61% off the SMA20 and 114.90% off the SMA50. The RSI metric on the 14-day chart is currently showing 84.29, and weekly volatility stands at 51.46%. When measured over the past 30 days, the indicator reaches 22.54%. Acurx Pharmaceuticals Inc (NASDAQ:ACXP)’s beta value is currently sitting at -1.39, while the Average True Range indicator is currently displaying 0.08.
To see how Acurx Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: ACXP stock’s performance was 167.24% in the latest trading, and -66.91% in the past year.
An evaluation of the daily trading volume of Acurx Pharmaceuticals Inc (NASDAQ:ACXP) indicates that the 3-month average is 182.89K.
Currently, records show that 22.40 million of the company’s shares remain outstanding. The insiders hold 13.17% of outstanding shares, whereas institutions hold 14.90%. However, since the stock’s price has seen 0.82% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
